Crossmark

Coacervate-mediated novel pancreatic cancer drug <i>Aleuria Aurantia</i> lectin delivery for augmented anticancer therapy

Published Online: 2022-07-22

Published Print: 2022-09-30

Authors

Kim, Sungjun

Choi, Yunyoung

Kim, Kyobum http://orcid.org/0000-0003-3678-2078
License Information

Text and Data Mining valid from 2022-07-22

Version of Record valid from 2022-07-22
More Information

Article History

Received: 20 May 2022

Accepted: 28 June 2022

First Online: 22 July 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current